摘要：Correction to:
Scientific Reports 10.1038/s41598-021-92416-4, published online 24 June 2021
The original version of this Article contained errors in Table 1, where the molecules were incorrectly displayed. The original Table
1 and accompanying legend appear below.
Table 1
Structure–activity relationship of 4-aminoquinazoline EGFR inhibitors against SARS-CoV-2 PL
pro.
Compound number
Generic name
R
1
R
2
R
3
R
4
R
5
IC
50 (µM) (range)
8
Tarloxotinib
Br
F
N
N
0.3 (0.1–0.5)
9
Tarloxotinib (ac)
Br
F
N
N
0.3 (0.1–0.4)
10
Pelitinib
Cl
Cl
> 100*
11
Afatinib
Cl
Cl
N
12 (11–16)
12
Dacomitinib
Cl
Cl
N
4 (3–5)
13
Gefitinib
Cl
Cl
N
7 (6–11)
*The range could not be established due to lack of potency.
The original Article has been corrected.
